Thursday, July 18th | 15 Tammuz 5779

Subscribe
May 16, 2019 8:23 am

Mayo Clinic and Israeli Health Companies to Create New Medical Technologies

avatar by JNS.org

Mayo Clinic in Rochester, Minn. Photo: Tony Webster/Flickr.

JNS.org – The Minnesota-based Mayo Clinic has signed a memorandum of understanding with the US branch of the Israel Innovation Authority to collaborate with Israeli firms to co-create new medical technologies, announced the two groups.

The MOU was signed on Tuesday at the MIXiii Biomed Conference and Exhibition in Tel Aviv.

“The focus of the cooperation will be health technologies, including in medical devices, diagnostics, software solutions and therapies, the parties said in a statement. The aim is to accelerate the availability of medical innovations to the public and introduce Israeli health-care technology” to the United States, reported The Times of Israel.

“The health market and especially pharma are among the fastest-growing industries in the world,” said Israeli Minister of Economy and Industry Eli Cohen in a statement. “The agreement signed between a global health-care brand such as Mayo Clinic and the Israel Innovation Authority constitutes a vote of confidence in Israel’s startup industry and innovations, further highlighting Israel’s key position in shaping the health landscape of the future.”

Related coverage

July 18, 2019 11:38 am
0

BBC Special on Circumcision Draws Mixed Reaction From UK Jewish Group

A British advocacy group for protecting the practice of circumcision expressed guarded criticism of a BBC special on the Jewish...

In 2016, the Mayo Clinic started its Israeli Startup Initiative to encourage innovation collaboration between the clinic and Israeli startups.

“We are excited for the opportunity to expand our outreach to Israeli innovators through this initiative, as they are a part of one of the most vibrant innovation ecosystems in the world,” said Amir Lerman, medical director of the Mayo Clinic Israeli Startup Initiative and a Mayo Clinic cardiologist.

Share this Story: Share On Facebook Share On Twitter

Let your voice be heard!

Join the Algemeiner

Algemeiner.com

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.